Cure My Disease

Don't miss your cure!

 Log in / Sign up

Plant sterol diet may help lower cholesterol in obesity

NCT ID NCT07696559

Disease control Sponsor: University of Lahore Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This trial investigates whether adding β-sitosterol, a natural plant sterol, to the diet can improve cholesterol levels in adults with grade II obesity and high cholesterol. Participants follow a controlled diet, with one group receiving β-sitosterol-enriched foods. The study measures changes in body mass index and blood lipid profile over the intervention period.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
β-sitosterol (a plant sterol)
What this could lead to
If it works, this could point toward a simple dietary approach to help manage high cholesterol in people with obesity.
What could go wrong
This is a small, early-stage trial with only 60 participants. The effect may be modest, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Jan 2026

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 55 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 25-55 years * Diagnosed with hyperlipidemia (LDL ≥ 130 mg/dL or Total Cholesterol ≥ 200 mg/dL) * BMI between 35.0-39.9 kg/m² * Willing to follow a prescribed diet plan for the entire study duration Exclusion Criteria: * Patients with sitosterolemia, kidney or liver diseases * Pregnant or lactating women * Current use of statins, fibrates, or plant sterol supplements * Individuals with food allergies to any prescribed ingredients

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hyperlipidemia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperlipidemia obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hyperlipidemia Obese individuals

Contacts and locations

Locations

  • The University of Lahore

    Lahore, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.